Tag: annual report
Smith & Wesson (SWBI) 2026 10-K Analysis: MD&A Filing Changes
Smith & Wesson (SWBI) 2026 10-K analysis comparing MD&A changes, sales growth, tariff pressure, debt reduction, and capital allocation versus 2025.
Smith & Wesson Brands (SWBI) 2026 10-K Analysis: MD&A Changes
Smith & Wesson Brands (SWBI) 2026 10-K analysis comparing the 17 June 2026 filing with its prior-year 10-K, highlighting the MD&A section’s biggest changes.
Vistagen Therapeutics (VTGN) 10-K Business Changes | 15 June 2026
Vistagen Therapeutics (VTGN)’s Business section changed the most among 7 companies that filed 10-Ks on 15 June 2026, each compared against its prior-year filing.